Blog
Researchers discover new biomarkers for stroke
October 29, 2020
Many strokes are missed when a clinician first examines the patient. That’s often because the classic stroke symptoms – drooping face, numbness in the arm, slurred speech – aren’t as obvious as they are in the most severely presenting cases. Despite less-obvious symptoms, these events can still lead to disability and death. Confirming a stroke […]
Urgent simultaneous requests for COVID-19 and ovarian cancer specimens
October 21, 2020
If you’re a client or regular reader, you know we’re committed to advancing the precision medicine revolution – the use of massive amounts of patient data to extract new insights about individuals, treatments and prognosis.
Older research could bring new insights for COVID-19 long haulers
October 6, 2020
Understanding the mechanisms behind the development of mono and CFS may well shed light on comparable mechanisms related to developing COVID-19 and “long COVID,” a condition characterized by CFS-like symptoms (problems with energy, memory and concentration) that endure for weeks and months after the acute COVID-19 infection phase.
Big volumes of specimen data help improve ovarian cancer prognosis
September 24, 2020
Human biospecimens contain massive volumes of potential data that can help researchers glean surprising new insights. That’s the case for an international team of researchers who have discovered that genetic signatures in ovarian cancer tissue can predict the patient’s survival more accurately than the combination of patient age and cancer stage.
The public health pro’s best friend
September 14, 2020
Labs and other canine friends can distinguish urine from a patient who has tested positive from cans of urine from noninfected patients, according to the Washington Post. Faced with an array of controls in the lab, they will even walk right by cake batter.
‘ALS on a Chip’ to Potentially Improve Personalized Medicine
August 27, 2020
A University of Central Florida research lab has developed “human-on-a-chip” technology that can be used to help assess the potential of new personalized therapy candidates for ALS.
COVID-19 updates: Vaccine development, obesity worries, and plasma therapy
August 18, 2020
There’s a lot of news on COVID-19 (as always). First, some very good news: Vaccine development is progressing at a surprisingly brisk pace, with researchers arriving at phase 3 trials in six months, instead of years, raising the possibility of an approved vaccine faster than ever.
New experimental blood test could transform Alzheimer’s diagnosis
August 6, 2020
Researchers at Lund University in Sweden have developed a potentially breakthrough blood test for Alzheimer’s disease, a debilitating and hard-to-diagnose condition that robs patients of their memory and independent function. If and when it’s approved for general use, the new experimental test could provide a quicker, cheaper, more widely available and more definitive way to diagnose the agonizing condition.
Researchers discover hundreds of new genetic variants linked to diabetes
July 23, 2020
The largest study of its kind has demonstrated the power of biobanking, genetics and data analytics to produce new medical insights from enormous pools of patients.
Liquid Biopsy sees progress for kidney and brain cancer
July 16, 2020
Cancer often progresses under the radar, especially in its early and more treatable stages. When symptoms do arise, definitive diagnosis often requires an invasive surgical procedure. So how can we diagnose cancer earlier for more people with less effort and less discomfort? Liquid biopsy is an emerging technology aimed at addressing all of these concerns, […]
Previous |
- © 2020 iSpecimen, Inc.
- All rights reserved.
|
|